PAVBLU FDA approval date

The FDA approved PAVBLU on 23 Aug 2024.

FDA approval date
23 Aug 2024

Drug identity has not yet been verified against registry records

Also recorded as AFLIBERCEPT-AYYH

Included trials

No linked trials for this drug yet. Browse all trials

PDUFA dates and FDA decisions

Date as reportedDrug / companyEventConditionEvidence
2024-08-23DayPAVBLUFDA original application approvalFDA approval decisionNot specifiedOpen original source
Read source excerpt

{"application_number": "BLA761298", "applicant_as_listed_by_fda": "AMGEN INC", "brand_names": ["PAVBLU"], "active_ingredients": ["AFLIBERCEPT-AYYH"], "submission_type": "ORIG", "submission_number": "1", "submission_status": "AP", "submission_status_date": "20240823", "matched_on": "drug record created from this FDA brand name"}

First seen: 06 Oct 2026 · Evidence last checked: 06 Oct 2026